Workability in Patients With Seropositive Rheumatoid Arthritis
1 other identifier
interventional
100
0 countries
N/A
Brief Summary
This study compares workability in subjects with seropositive rheumatoid arthritis (RA) in the working age with high and low disease activity. Further interest is to clarify the influence of frailty, functional ability and muscle strength on workability and to determine the effect of disease activity on selected physiological needs (sleep quality, sexual functioning). Methods include a physical examination, questionnaires and physical tests.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2015
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 10, 2015
CompletedStudy Start
First participant enrolled
October 1, 2015
CompletedFirst Posted
Study publicly available on registry
October 21, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2016
CompletedMarch 6, 2017
March 1, 2017
10 months
July 10, 2015
March 3, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
Workability
Self-reported work ability will be measured by the work ability index (WAI). The WAI is a questionnaire consisting of seven subscales: current work ability compared with the lifetime best; work ability in relation to the demands of the job; number of current diseases diagnosed by a physician; estimated work impairment due to disease; sick leave during the past 12 month; own prognosis of work ability 2 years from now; and mental resources. The cumulative index of WAI ranges from 7 to 49 points. It is then divided into 4 categories: poor (7-27 points), moderate (28-36 points), good (37-43 points) and excellent work ability (44-49 points).
Day 1
Secondary Outcomes (7)
Functional Disability
Day 1
Frailty
Day 1
Lower-extremity function
Day 1
Musculus quadriceps femoris strength
Day1
Hand grip strength
Day1
- +2 more secondary outcomes
Other Outcomes (3)
IL-6
Day1
TNF-alpha
Day1
CRP
Day 1
Study Arms (1)
Single arm assessment
OTHERCross sectional assessment of workability, functional disability, frailty, muscle strength, quality of sleep and sexual functioning of rheumatoid arthritis patients with different disease activity levels.
Interventions
Assessment of workability, functional disability, frailty, muscle strength, quality of sleep and sexual functioning
Eligibility Criteria
You may qualify if:
- Seropositive rheumatoid arthritis according to EULAR Criteria
- Age ≥18 and ≤65 years
You may not qualify if:
- Cannot understand questionnaires in the languages provided (German , English, Turkish, Serb o-Croatian)
- Cannot understand instructions for physical tests/assessments.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Kaiser Franz Josef Hospitallead
- Landsteiner Institutcollaborator
Related Publications (1)
Berner C, Erlacher L, Quittan M, Fenzl KH, Dorner TE. Workability and Muscle Strength in Patients With Seropositive Rheumatoid Arthritis: Survey Study Protocol. JMIR Res Protoc. 2017 Mar 2;6(3):e36. doi: 10.2196/resprot.6449.
PMID: 28254736DERIVED
Study Officials
- STUDY CHAIR
Thomas Dorner, Assoc Prof, MD, MPH
Institute of Social Medicine and Centre of Public Health
- PRINCIPAL INVESTIGATOR
Ludwig Erlacher, Prof. MD
Kaiser Franz Josefs Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prof. Dr. Ludwig Erlacher
Study Record Dates
First Submitted
July 10, 2015
First Posted
October 21, 2015
Study Start
October 1, 2015
Primary Completion
August 1, 2016
Study Completion
November 1, 2016
Last Updated
March 6, 2017
Record last verified: 2017-03